Pre-order Enquiry
Request Free Sample
Global PCR-based Enteric Disease Testing Market Insights and Forecast to 2028
SKU ID : QYR-20496813 | Publishing Date : 15-Mar-2022 | No. of pages : 129
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global PCR-based Enteric Disease Testing Market Insights and Forecast to 2028
1 Report Business Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Analyzers/Instruments
1.2.3 Kits/Panels
1.3 Market by Application
1.3.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clostridium Difficile
1.3.3 Campylobacteriosis
1.3.4 Cholera
1.3.5 E. coli Infection
1.3.6 H. pylori Infection
1.3.7 Salmonellosis
1.3.8 Shigellosis
1.3.9 Rotavirus Infection
1.3.10 Norovirus Infection
1.3.11 Parasitic Enteric Disease
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PCR-based Enteric Disease Testing Market Perspective (2017-2028)
2.2 PCR-based Enteric Disease Testing Growth Trends by Region
2.2.1 PCR-based Enteric Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 PCR-based Enteric Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 PCR-based Enteric Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 PCR-based Enteric Disease Testing Market Dynamics
2.3.1 PCR-based Enteric Disease Testing Industry Trends
2.3.2 PCR-based Enteric Disease Testing Market Drivers
2.3.3 PCR-based Enteric Disease Testing Market Challenges
2.3.4 PCR-based Enteric Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR-based Enteric Disease Testing Players by Revenue
3.1.1 Global Top PCR-based Enteric Disease Testing Players by Revenue (2017-2022)
3.1.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PCR-based Enteric Disease Testing Revenue
3.4 Global PCR-based Enteric Disease Testing Market Concentration Ratio
3.4.1 Global PCR-based Enteric Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR-based Enteric Disease Testing Revenue in 2021
3.5 PCR-based Enteric Disease Testing Key Players Head office and Area Served
3.6 Key Players PCR-based Enteric Disease Testing Product Solution and Service
3.7 Date of Enter into PCR-based Enteric Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR-based Enteric Disease Testing Breakdown Data by Type
4.1 Global PCR-based Enteric Disease Testing Historic Market Size by Type (2017-2022)
4.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2023-2028)
5 PCR-based Enteric Disease Testing Breakdown Data by Application
5.1 Global PCR-based Enteric Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America PCR-based Enteric Disease Testing Market Size (2017-2028)
6.2 North America PCR-based Enteric Disease Testing Market Size by Type
6.2.1 North America PCR-based Enteric Disease Testing Market Size by Type (2017-2022)
6.2.2 North America PCR-based Enteric Disease Testing Market Size by Type (2023-2028)
6.2.3 North America PCR-based Enteric Disease Testing Market Share by Type (2017-2028)
6.3 North America PCR-based Enteric Disease Testing Market Size by Application
6.3.1 North America PCR-based Enteric Disease Testing Market Size by Application (2017-2022)
6.3.2 North America PCR-based Enteric Disease Testing Market Size by Application (2023-2028)
6.3.3 North America PCR-based Enteric Disease Testing Market Share by Application (2017-2028)
6.4 North America PCR-based Enteric Disease Testing Market Size by Country
6.4.1 North America PCR-based Enteric Disease Testing Market Size by Country (2017-2022)
6.4.2 North America PCR-based Enteric Disease Testing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe PCR-based Enteric Disease Testing Market Size (2017-2028)
7.2 Europe PCR-based Enteric Disease Testing Market Size by Type
7.2.1 Europe PCR-based Enteric Disease Testing Market Size by Type (2017-2022)
7.2.2 Europe PCR-based Enteric Disease Testing Market Size by Type (2023-2028)
7.2.3 Europe PCR-based Enteric Disease Testing Market Share by Type (2017-2028)
7.3 Europe PCR-based Enteric Disease Testing Market Size by Application
7.3.1 Europe PCR-based Enteric Disease Testing Market Size by Application (2017-2022)
7.3.2 Europe PCR-based Enteric Disease Testing Market Size by Application (2023-2028)
7.3.3 Europe PCR-based Enteric Disease Testing Market Share by Application (2017-2028)
7.4 Europe PCR-based Enteric Disease Testing Market Size by Country
7.4.1 Europe PCR-based Enteric Disease Testing Market Size by Country (2017-2022)
7.4.2 Europe PCR-based Enteric Disease Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type
8.2.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific PCR-based Enteric Disease Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application
8.3.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific PCR-based Enteric Disease Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region
8.4.1 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific PCR-based Enteric Disease Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America PCR-based Enteric Disease Testing Market Size (2017-2028)
9.2 Latin America PCR-based Enteric Disease Testing Market Size by Type
9.2.1 Latin America PCR-based Enteric Disease Testing Market Size by Type (2017-2022)
9.2.2 Latin America PCR-based Enteric Disease Testing Market Size by Type (2023-2028)
9.2.3 Latin America PCR-based Enteric Disease Testing Market Share by Type (2017-2028)
9.3 Latin America PCR-based Enteric Disease Testing Market Size by Application
9.3.1 Latin America PCR-based Enteric Disease Testing Market Size by Application (2017-2022)
9.3.2 Latin America PCR-based Enteric Disease Testing Market Size by Application (2023-2028)
9.3.3 Latin America PCR-based Enteric Disease Testing Market Share by Application (2017-2028)
9.4 Latin America PCR-based Enteric Disease Testing Market Size by Country
9.4.1 Latin America PCR-based Enteric Disease Testing Market Size by Country (2017-2022)
9.4.2 Latin America PCR-based Enteric Disease Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type
10.2.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa PCR-based Enteric Disease Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application
10.3.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa PCR-based Enteric Disease Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country
10.4.1 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa PCR-based Enteric Disease Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Vela Diagnostics
11.2.1 Vela Diagnostics Company Details
11.2.2 Vela Diagnostics Business Overview
11.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction
11.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.2.5 Vela Diagnostics Recent Developments
11.3 CorisBioconcept
11.3.1 CorisBioconcept Company Details
11.3.2 CorisBioconcept Business Overview
11.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction
11.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.3.5 CorisBioconcept Recent Developments
11.4 Meridian Life Science
11.4.1 Meridian Life Science Company Details
11.4.2 Meridian Life Science Business Overview
11.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction
11.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.4.5 Meridian Life Science Recent Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction
11.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.5.5 Bio-Rad Laboratories Recent Developments
11.6 Abbott (ALERE)
11.6.1 Abbott (ALERE) Company Details
11.6.2 Abbott (ALERE) Business Overview
11.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction
11.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.6.5 Abbott (ALERE) Recent Developments
11.7 bioMerieux SA
11.7.1 bioMerieux SA Company Details
11.7.2 bioMerieux SA Business Overview
11.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction
11.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.7.5 bioMerieux SA Recent Developments
11.8 Trinity Biotech
11.8.1 Trinity Biotech Company Details
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction
11.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.8.5 Trinity Biotech Recent Developments
11.9 DiaSorin Molecular
11.9.1 DiaSorin Molecular Company Details
11.9.2 DiaSorin Molecular Business Overview
11.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction
11.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.9.5 DiaSorin Molecular Recent Developments
11.10 Etta Healthcare (Ovagene Oncology)
11.10.1 Etta Healthcare (Ovagene Oncology) Company Details
11.10.2 Etta Healthcare (Ovagene Oncology) Business Overview
11.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction
11.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.10.5 Etta Healthcare (Ovagene Oncology) Recent Developments
11.11 ExcitePCR (PositiveID Corporation)
11.11.1 ExcitePCR (PositiveID Corporation) Company Details
11.11.2 ExcitePCR (PositiveID Corporation) Business Overview
11.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction
11.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.11.5 ExcitePCR (PositiveID Corporation) Recent Developments
11.12 Flow Alliance
11.12.1 Flow Alliance Company Details
11.12.2 Flow Alliance Business Overview
11.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction
11.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.12.5 Flow Alliance Recent Developments
11.13 Fluid-Screen
11.13.1 Fluid-Screen Company Details
11.13.2 Fluid-Screen Business Overview
11.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction
11.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.13.5 Fluid-Screen Recent Developments
11.14 FluimediX
11.14.1 FluimediX Company Details
11.14.2 FluimediX Business Overview
11.14.3 FluimediX PCR-based Enteric Disease Testing Introduction
11.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.14.5 FluimediX Recent Developments
11.15 Fluxergy
11.15.1 Fluxergy Company Details
11.15.2 Fluxergy Business Overview
11.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction
11.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.15.5 Fluxergy Recent Developments
11.16 Focus Diagnostics (DiaSorin Molecular)
11.16.1 Focus Diagnostics (DiaSorin Molecular) Company Details
11.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview
11.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction
11.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Developments
11.17 Future Horizon Scientific
11.17.1 Future Horizon Scientific Company Details
11.17.2 Future Horizon Scientific Business Overview
11.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction
11.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.17.5 Future Horizon Scientific Recent Developments
11.18 Genalyte
11.18.1 Genalyte Company Details
11.18.2 Genalyte Business Overview
11.18.3 Genalyte PCR-based Enteric Disease Testing Introduction
11.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.18.5 Genalyte Recent Developments
11.19 GeneFluidics
11.19.1 GeneFluidics Company Details
11.19.2 GeneFluidics Business Overview
11.19.3 GeneFluidics PCR-based Enteric Disease Testing Introduction
11.19.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.19.5 GeneFluidics Recent Developments
11.20 GenSpeed Biotech
11.20.1 GenSpeed Biotech Company Details
11.20.2 GenSpeed Biotech Business Overview
11.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction
11.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.20.5 GenSpeed Biotech Recent Developments
11.21 Gulf Bio Analytical
11.21.1 Gulf Bio Analytical Company Details
11.21.2 Gulf Bio Analytical Business Overview
11.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction
11.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.21.5 Gulf Bio Analytical Recent Developments
11.22 Hahn-Schickard
11.22.1 Hahn-Schickard Company Details
11.22.2 Hahn-Schickard Business Overview
11.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction
11.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.22.5 Hahn-Schickard Recent Developments
11.23 Helvoet
11.23.1 Helvoet Company Details
11.23.2 Helvoet Business Overview
11.23.3 Helvoet PCR-based Enteric Disease Testing Introduction
11.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.23.5 Helvoet Recent Developments
11.24 HemoCue
11.24.1 HemoCue Company Details
11.24.2 HemoCue Business Overview
11.24.3 HemoCue PCR-based Enteric Disease Testing Introduction
11.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.24.5 HemoCue Recent Developments
11.25 Danaher
11.25.1 Danaher Company Details
11.25.2 Danaher Business Overview
11.25.3 Danaher PCR-based Enteric Disease Testing Introduction
11.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.25.5 Danaher Recent Developments
11.26 IDEX Health&Science
11.26.1 IDEX Health&Science Company Details
11.26.2 IDEX Health&Science Business Overview
11.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction
11.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.26.5 IDEX Health&Science Recent Developments
11.27 iLine Microsystems
11.27.1 iLine Microsystems Company Details
11.27.2 iLine Microsystems Business Overview
11.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction
11.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.27.5 iLine Microsystems Recent Developments
11.28 Inflammatix
11.28.1 Inflammatix Company Details
11.28.2 Inflammatix Business Overview
11.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction
11.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2017-2022)
11.28.5 Inflammatix Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global PCR-based Enteric Disease Testing Market Insights and Forecast to 2028
List of TablesTable 1. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Analyzers/Instruments
Table 3. Key Players of Kits/Panels
Table 4. Global PCR-based Enteric Disease Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global PCR-based Enteric Disease Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global PCR-based Enteric Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global PCR-based Enteric Disease Testing Market Share by Region (2017-2022)
Table 8. Global PCR-based Enteric Disease Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global PCR-based Enteric Disease Testing Market Share by Region (2023-2028)
Table 10. PCR-based Enteric Disease Testing Market Trends
Table 11. PCR-based Enteric Disease Testing Market Drivers
Table 12. PCR-based Enteric Disease Testing Market Challenges
Table 13. PCR-based Enteric Disease Testing Market Restraints
Table 14. Global PCR-based Enteric Disease Testing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global PCR-based Enteric Disease Testing Revenue Share by Players (2017-2022)
Table 16. Global Top PCR-based Enteric Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR-based Enteric Disease Testing as of 2021)
Table 17. Ranking of Global Top PCR-based Enteric Disease Testing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by PCR-based Enteric Disease Testing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PCR-based Enteric Disease Testing Product Solution and Service
Table 21. Date of Enter into PCR-based Enteric Disease Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2017-2022)
Table 25. Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global PCR-based Enteric Disease Testing Revenue Market Share by Type (2023-2028)
Table 27. Global PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global PCR-based Enteric Disease Testing Revenue Share by Application (2017-2022)
Table 29. Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global PCR-based Enteric Disease Testing Revenue Share by Application (2023-2028)
Table 31. North America PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America PCR-based Enteric Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America PCR-based Enteric Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe PCR-based Enteric Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe PCR-based Enteric Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific PCR-based Enteric Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific PCR-based Enteric Disease Testing Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America PCR-based Enteric Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America PCR-based Enteric Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa PCR-based Enteric Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific PCR-based Enteric Disease Testing Product
Table 64. Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Developments
Table 66. Vela Diagnostics Company Details
Table 67. Vela Diagnostics Business Overview
Table 68. Vela Diagnostics PCR-based Enteric Disease Testing Product
Table 69. Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 70. Vela Diagnostics Recent Developments
Table 71. CorisBioconcept Company Details
Table 72. CorisBioconcept Business Overview
Table 73. CorisBioconcept PCR-based Enteric Disease Testing Product
Table 74. CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 75. CorisBioconcept Recent Developments
Table 76. Meridian Life Science Company Details
Table 77. Meridian Life Science Business Overview
Table 78. Meridian Life Science PCR-based Enteric Disease Testing Product
Table 79. Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 80. Meridian Life Science Recent Developments
Table 81. Bio-Rad Laboratories Company Details
Table 82. Bio-Rad Laboratories Business Overview
Table 83. Bio-Rad Laboratories PCR-based Enteric Disease Testing Product
Table 84. Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 85. Bio-Rad Laboratories Recent Developments
Table 86. Abbott (ALERE) Company Details
Table 87. Abbott (ALERE) Business Overview
Table 88. Abbott (ALERE) PCR-based Enteric Disease Testing Product
Table 89. Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 90. Abbott (ALERE) Recent Developments
Table 91. bioMerieux SA Company Details
Table 92. bioMerieux SA Business Overview
Table 93. bioMerieux SA PCR-based Enteric Disease Testing Product
Table 94. bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 95. bioMerieux SA Recent Developments
Table 96. Trinity Biotech Company Details
Table 97. Trinity Biotech Business Overview
Table 98. Trinity Biotech PCR-based Enteric Disease Testing Product
Table 99. Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 100. Trinity Biotech Recent Developments
Table 101. DiaSorin Molecular Company Details
Table 102. DiaSorin Molecular Business Overview
Table 103. DiaSorin Molecular PCR-based Enteric Disease Testing Product
Table 104. DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 105. DiaSorin Molecular Recent Developments
Table 106. Etta Healthcare (Ovagene Oncology) Company Details
Table 107. Etta Healthcare (Ovagene Oncology) Business Overview
Table 108. Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Product
Table 109. Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 110. Etta Healthcare (Ovagene Oncology) Recent Developments
Table 111. ExcitePCR (PositiveID Corporation) Company Details
Table 112. ExcitePCR (PositiveID Corporation) Business Overview
Table 113. ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Product
Table 114. ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 115. ExcitePCR (PositiveID Corporation) Recent Developments
Table 116. Flow Alliance Company Details
Table 117. Flow Alliance Business Overview
Table 118. Flow Alliance PCR-based Enteric Disease Testing Product
Table 119. Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 120. Flow Alliance Recent Developments
Table 121. Fluid-Screen Company Details
Table 122. Fluid-Screen Business Overview
Table 123. Fluid-Screen PCR-based Enteric Disease Testing Product
Table 124. Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 125. Fluid-Screen Recent Developments
Table 126. FluimediX Company Details
Table 127. FluimediX Business Overview
Table 128. FluimediX PCR-based Enteric Disease Testing Product
Table 129. FluimediX Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 130. FluimediX Recent Developments
Table 131. Fluxergy Company Details
Table 132. Fluxergy Business Overview
Table 133. Fluxergy PCR-based Enteric Disease Testing Product
Table 134. Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 135. Fluxergy Recent Developments
Table 136. Focus Diagnostics (DiaSorin Molecular) Company Details
Table 137. Focus Diagnostics (DiaSorin Molecular) Business Overview
Table 138. Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Product
Table 139. Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 140. Focus Diagnostics (DiaSorin Molecular) Recent Developments
Table 141. Future Horizon Scientific Company Details
Table 142. Future Horizon Scientific Business Overview
Table 143. Future Horizon Scientific PCR-based Enteric Disease Testing Product
Table 144. Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 145. Future Horizon Scientific Recent Developments
Table 146. Genalyte Company Details
Table 147. Genalyte Business Overview
Table 148. Genalyte PCR-based Enteric Disease Testing Product
Table 149. Genalyte Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 150. Genalyte Recent Developments
Table 151. GeneFluidics Company Details
Table 152. GeneFluidics Business Overview
Table 153. GeneFluidics PCR-based Enteric Disease Testing Product
Table 154. GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 155. GeneFluidics Recent Developments
Table 156. GenSpeed Biotech Company Details
Table 157. GenSpeed Biotech Business Overview
Table 158. GenSpeed Biotech PCR-based Enteric Disease Testing Product
Table 159. GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 160. GenSpeed Biotech Recent Developments
Table 161. Gulf Bio Analytical Company Details
Table 162. Gulf Bio Analytical Business Overview
Table 163. Gulf Bio Analytical PCR-based Enteric Disease Testing Product
Table 164. Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 165. Gulf Bio Analytical Recent Developments
Table 166. Hahn-Schickard Company Details
Table 167. Hahn-Schickard Business Overview
Table 168. Hahn-Schickard PCR-based Enteric Disease Testing Product
Table 169. Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 170. Hahn-Schickard Recent Developments
Table 171. Helvoet Company Details
Table 172. Helvoet Business Overview
Table 173. Helvoet PCR-based Enteric Disease Testing Product
Table 174. Helvoet Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 175. Helvoet Recent Developments
Table 176. HemoCue Company Details
Table 177. HemoCue Business Overview
Table 178. HemoCue PCR-based Enteric Disease Testing Product
Table 179. HemoCue Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 180. HemoCue Recent Developments
Table 181. Danaher Company Details
Table 182. Danaher Business Overview
Table 183. Danaher PCR-based Enteric Disease Testing Product
Table 184. Danaher Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 185. Danaher Recent Developments
Table 186. IDEX Health&Science Company Details
Table 187. IDEX Health&Science Business Overview
Table 188. IDEX Health&Science PCR-based Enteric Disease Testing Product
Table 189. IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 190. IDEX Health&Science Recent Developments
Table 191. iLine Microsystems Company Details
Table 192. iLine Microsystems Business Overview
Table 193. iLine Microsystems PCR-based Enteric Disease Testing Product
Table 194. iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 195. iLine Microsystems Recent Developments
Table 196. Inflammatix Company Details
Table 197. Inflammatix Business Overview
Table 198. Inflammatix PCR-based Enteric Disease Testing Product
Table 199. Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2017-2022) & (US$ Million)
Table 200. Inflammatix Recent Developments
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PCR-based Enteric Disease Testing Market Share by Type: 2021 VS 2028
Figure 2. Analyzers/Instruments Features
Figure 3. Kits/Panels Features
Figure 4. Global PCR-based Enteric Disease Testing Market Share by Application: 2021 VS 2028
Figure 5. Clostridium Difficile Case Studies
Figure 6. Campylobacteriosis Case Studies
Figure 7. Cholera Case Studies
Figure 8. E. coli Infection Case Studies
Figure 9. H. pylori Infection Case Studies
Figure 10. Salmonellosis Case Studies
Figure 11. Shigellosis Case Studies
Figure 12. Rotavirus Infection Case Studies
Figure 13. Norovirus Infection Case Studies
Figure 14. Parasitic Enteric Disease Case Studies
Figure 15. PCR-based Enteric Disease Testing Report Years Considered
Figure 16. Global PCR-based Enteric Disease Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global PCR-based Enteric Disease Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global PCR-based Enteric Disease Testing Market Share by Region: 2021 VS 2028
Figure 19. Global PCR-based Enteric Disease Testing Market Share by Players in 2021
Figure 20. Global Top PCR-based Enteric Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR-based Enteric Disease Testing as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by PCR-based Enteric Disease Testing Revenue in 2021
Figure 22. North America PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 23. North America PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028)
Figure 24. North America PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028)
Figure 25. North America PCR-based Enteric Disease Testing Market Size Share by Country (2017-2028)
Figure 26. United States PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Canada PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 29. Europe PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028)
Figure 30. Europe PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028)
Figure 31. Europe PCR-based Enteric Disease Testing Market Size Share by Country (2017-2028)
Figure 32. Germany PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 39. Asia Pacific PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028)
Figure 40. Asia Pacific PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028)
Figure 41. Asia Pacific PCR-based Enteric Disease Testing Market Size Share by Region (2017-2028)
Figure 42. China PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 48. Latin America PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Latin America PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028)
Figure 50. Latin America PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028)
Figure 51. Latin America PCR-based Enteric Disease Testing Market Size Share by Country (2017-2028)
Figure 52. Mexico PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Brazil PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa PCR-based Enteric Disease Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa PCR-based Enteric Disease Testing Market Size Market Share by Type (2017-2028)
Figure 56. Middle East and Africa PCR-based Enteric Disease Testing Market Size Market Share by Application (2017-2028)
Figure 57. Middle East and Africa PCR-based Enteric Disease Testing Market Size Share by Country (2017-2028)
Figure 58. Turkey PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UAE PCR-based Enteric Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 62. Vela Diagnostics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 63. CorisBioconcept Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 64. Meridian Life Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 65. Bio-Rad Laboratories Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 66. Abbott (ALERE) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 67. bioMerieux SA Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 68. Trinity Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 69. DiaSorin Molecular Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 70. Etta Healthcare (Ovagene Oncology) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 71. ExcitePCR (PositiveID Corporation) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 72. Flow Alliance Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 73. Fluid-Screen Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 74. FluimediX Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 75. Fluxergy Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 76. Focus Diagnostics (DiaSorin Molecular) Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 77. Future Horizon Scientific Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 78. Genalyte Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 79. GeneFluidics Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 80. GenSpeed Biotech Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 81. Gulf Bio Analytical Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 82. Hahn-Schickard Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 83. Helvoet Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 84. HemoCue Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 85. Danaher Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 86. IDEX Health&Science Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 87. iLine Microsystems Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 88. Inflammatix Revenue Growth Rate in PCR-based Enteric Disease Testing Business (2017-2022)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Keyplayers in Global PCR-based Enteric Disease Testing Market Insights and Forecast to 2028
Thermo Fisher ScientificVela Diagnostics
CorisBioconcept
Meridian Life Science
Bio-Rad Laboratories
Abbott (ALERE)
bioMerieux SA
Trinity Biotech
DiaSorin Molecular
Etta Healthcare (Ovagene Oncology)
ExcitePCR (PositiveID Corporation)
Flow Alliance
Fluid-Screen
FluimediX
Fluxergy
Focus Diagnostics (DiaSorin Molecular)
Future Horizon Scientific
Genalyte
GeneFluidics
GenSpeed Biotech
Gulf Bio Analytical
Hahn-Schickard
Helvoet
HemoCue
Danaher
IDEX Health&Science
iLine Microsystems
Inflammatix
